Simulations Plus (SLP) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- S&P 500, Nasdaq climb as AI-linked stocks recover ahead of earnings
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Oil slips from five-month highs with Hormuz crossings, Russian sanctions waiver in focus
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
- Brazil's Bolsonaro, Lula spar in first debate as personal attacks fly
- Cerebras Systems falls as TD Cowen cuts price target
- Glass House Brands posts Q3 revenue of $56.8M, board member exits
- S&P 500, Nasdaq climb as AI-linked stocks recover ahead of earnings
- Nvidia wins CPU business from Modal, previously exclusive to AMD and Intel
Simulations Plus Reports Second Quarter FY2016 Financial Results
April 13, 2016 4:01 PM EDTRecord second quarter as revenues grow 12.9%, net income up 18%
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for all phases of pharmaceutical discovery and development from the earliest discovery through all phases of clinical trials, today reported financial results for its second quarter of fiscal year 2016, the period ended February 29, 2016 (2QFY16).
2QFY16 highlights compared with 2QFY15:
Net revenues increased 12.9%, or $590,000, to $5.16 million from $4.57 million Gross profit increased 13.3%, or $457,000, to $3.90 million from $3.44 million... More


